BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28301623)

  • 1. Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence.
    Ocampo-Garza J; Gioia Di Chiacchio N; Haneke E; le Voci F; Paschoal FM
    J Drugs Dermatol; 2017 Mar; 16(3):268-270. PubMed ID: 28301623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of invasive melanoma with topical imiquimod.
    Moon SD; Spencer JM
    J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Muñoz CM; Sánchez JL; Martín-García RF
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod in the treatment of metastatic melanoma to skin.
    Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
    Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
    [No Abstract]   [Full Text] [Related]  

  • 5. Conservative management of extramammary paget disease with imiquimod.
    Baiocchi G; Begnami MD; Fukazawa EM; Surima WS; Badiglian-Filho L; Costa FD; Oliveira RA; Faloppa CC; Kumagai LY; Soares FA
    J Low Genit Tract Dis; 2012 Jan; 16(1):59-63. PubMed ID: 21964211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review.
    Park AJ; Paul J; Chapman MS; Samie FH
    Dermatol Surg; 2017 Aug; 43(8):1017-1022. PubMed ID: 28328708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of imiquimod for residual acral melanoma.
    Sue GR; Hanlon A; Lazova R; Narayan D
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25188932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
    van Meurs T; van Doorn R; Kirtschig G
    Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
    [No Abstract]   [Full Text] [Related]  

  • 9. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
    Ellis LZ; Cohen JL; High W; Stewart L
    Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
    Fisher GH; Lang PG
    Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
    [No Abstract]   [Full Text] [Related]  

  • 12. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells.
    Savarese I; Papi F; D'Errico A; Gori A; Grazzini M; Vannucchi M; Massi D; De Giorgi V
    Clin Exp Dermatol; 2015 Jan; 40(1):27-30. PubMed ID: 25252087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.
    Vereecken P; Mathieu A; Laporte M; Petein M; Velu T; Awada A; Heenen M
    Dermatology; 2003; 206(3):279-80. PubMed ID: 12673091
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
    Rivas-Tolosa N; Ortiz-Brugués A; Toledo-Pastrana T; Baradad M; Traves V; Soriano V; Sanmartín V; Requena C; Martí R; Nagore E
    J Dermatol; 2016 May; 43(5):553-6. PubMed ID: 26660713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
    Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
    Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical imiquimod clears invasive melanoma.
    Grady BE; Spencer JM
    Cutis; 2016 Nov; 98(5):E28-E30. PubMed ID: 28040822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
    Swetter SM; Chen FW; Kim DD; Egbert BM
    J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.